Microfluidic Controllable Preparation of Iodine‐131‐Labeled Microspheres for Radioembolization Therapy of Liver Tumors
Authors:
- 12 July 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (21) , e2300873
Abstract
Transcatheter arterial radioembolization (TARE) is of great significance for the treatment of advanced hepatocellular carcinoma (HCC). However, the existing radioembolic microspheres still have problems such as non‐degradability, non‐uniform size, and inability to directly monitor in vivo, which hinders the development of TARE. In this paper, a novel radioembolic agent, 131I‐labeled methacrylated gelatin microspheres (131I‐GMs), is prepared for the treatment of HCC. Water‐in‐oil (W/O) emulsion templates are prepared by a simple one‐step microfluidic method to obtain methacrylated gelatin microspheres (GMs) after UV irradiation. A series of GMs with uniform and controllable size is obtained by adjusting the flow rate of each fluid. Both air‐dried and freeze‐dried GMs can quickly restore their original shape and size, and still have good monodispersity, elasticity, and biocompatibility. The radiolabeling experiments show that 131I can efficiently bind to GMs by chloramine‐T method, and the obtained 131I‐GMs have good radioactive stability in vitro. The results of in vivo TARE treatment in rats show that 131I‐GMs can be well retained in the hepatic artery and have a good inhibitory effect on the progression of liver cancer, showing the potential for the treatment of HCC.Keywords
Funding Information
- National Natural Science Foundation of China (22078202, 21991101)
This publication has 48 references indexed in Scilit:
- X-ray Visible and Uniform Alginate Microspheres Loaded with in Situ Synthesized BaSO4 Nanoparticles for in Vivo Transcatheter Arterial EmbolizationBiomacromolecules, 2015
- Effect of131I Gelatin Microspheres on Hepatocellular Carcinoma in Nude Mice and its Distribution after Intratumoral InjectionRadiation Research, 2014
- In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug releaseActa Biomaterialia, 2013
- Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation studyThe Lancet Oncology, 2012
- Embolization of liver tumors: Past, present and futureWorld Journal of Radiology, 2012
- Meta‐analysis of interstitial pneumonia in studies evaluating iodine‐131‐labeled lipiodol for hepatocellular carcinoma using exact likelihood approachPharmacoepidemiology and Drug Safety, 2011
- Directin vivoinjection of131I-GMS and its distribution and excretion in rabbitWorld Journal of Gastroenterology, 2010
- Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancerNuclear Medicine and Biology, 2008
- Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisHepatology, 2007
- Mechanical strength of single microcapsules determined by a novel micromanipulation techniqueJournal of Microencapsulation, 1999